For French’s®, We Promise is not just a statement or a seal on mustard and ketchup bottles, it’s a mobilizing community call to action to help the 42 million people who struggle with hunger in America and to help put food on their tables. That is why they have teamed up with Feeding America®, the nation’s largest domestic hunger-relief organization, to encourage the community to join them in providing 10 million meals* to people in need through its nationwide network of 200 food banks. French’s has created a simple and easy way to help consumers get involved with the touch of a button on their computer or mobile device.
To view the multimedia release go to:
https://www.multivu.com/players/English/8107851-frenchs-feeding-america-fight-hunger/
E-Alternative Solutions (EAS), a sister company to Jacksonville-based Swisher International, today launched a national advertising campaign for the Cue™ Vapor System (Cue) (patent pending), a breakthrough alternative to smoking. Cue is vaping made simple, providing fulfilling satisfaction in a premium-performance, stylish device that any adult smoker can operate with just the click of a cartridge and the push of a button. The closed system enables consumers to sidestep the complicated, and sometimes messy, process of using typical vaping devices. Cue is available for purchase online with appropriate age verification by visiting www.cuevapor.com.
To view the multimedia release go to:
https://www.multivu.com/players/English/8038851-e-alternative-solutions-eas-cue-vapor-system/
Varian Medical Systems (NYSE: VAR) today is introducing the Halcyon™ system, an entirely new device for cancer treatment. Engineered to revolutionize clinical workflow, Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT). This new treatment system is designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients.
“The global cancer challenge is enormous,” said Kolleen Kennedy, president of Varian's Oncology Systems business. “It is expected that there will be 24.6 million cancer cases diagnosed annually by 2030, and there is an acute shortage of equipment and trained clinicians. With the innovations in this new technology platform, the system will deliver high quality Halcyon treatments that empower clinicians to care for many more patients. At Varian we are very excited with the introduction of Halcyon to be taking another big step toward advancing cost-effective cancer care worldwide.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8065951-varian-medical-systems-halcyon-cancer-treatment/
